Table 5: Laser treatment response according to age, gender, type of fungi, clinical type of onychomycosis, and location.

PatientsExcellent response (>75%)Very good response (50–74)Good response (25–49)Moderate response (10–24%)Low response (>9%)No response (0%)

Gender
 Female10 (10.6%)44 (46.8%)25 (26.6%)10 (10.6%)0 (0.0%)5 (5.3%)
 Male2 (5.4%)9 (24.3%)16 (43.2%)9 (24.3%)0 (0.0%)1 (2.7%)
Age
 <30 y.o3 (15.0%)4 (20.0%)10 (50.0%)2 (10.0%)0 (0.0%)1 (5.0%)
 30–609 (10.5%) 37 (43.0%)24 (27.9%)13 (15.1%)0 (0.0%)3 (3.5%)
 >600 (0.0%)12 (50.0%)6 (25.0%)4 (16.7%)0 (0.0%)2 (8.3%)
Onychomycosis severity
 Mild3 (50.0%)2 (33.3%)1 (16.7%)0 (0.0%)0 (0.0%)0 (0.0%)
 Moderate5 (13.5%)23 (62.2%)9 (24.3%)0 (0.0%)0 (0.0%)0 (0.0%)
 Severe4 (4.5%)28 (31.8%)31 (35.2%)19 (21.6%)0 (0.0%)6 (6.8%)
Types of fungi
 T. rubrum 10 (9.3%)51 (47.2%)38 (35.2%)8 (7.4%)0 (0.0%)1 (0.9%)
 Candida 1 (5.3%)1 (5.3%)3 (15.8%)10 (52.6%)0 (0.0%)4 (21.1%)
 Non dermatophytes 1 (25.0%)1 (25.0%)0 (0.0%)10 (0.0%)1 (25.0%)
 T. mentographytes 9 (9.4%)48 (50.0%)35 (36.5%)4 (4.2%)0 (0.0%)0 (0.0%)
Clinical type of onychomycosis
 Distal subungual9 (7.3%)50 (40.7%)40 (32.5%)18 (14.6%)0 (0.0%)6 (4.9%)
 Proximal  subungual0 (0.0%)1 (100.0%)0 (0.0%)0 (0.0%)0 (0.0%)0 (0.0%)
 Superficial white1 (50.0%)0 (0.0%)0 (0.0%)1 (50.0%)0 (0.0%)0 (0.0%)
 Dystrophic 2 (4.3%)14 (29.8%)17 (36.2%)11 (23.4%)0 (0.0%)3 (6.4%)
 Lateral edge2 (4.3%)5 (38.5%)5 (38.5%)0 (0.0%)0 (0.0%)1 (7.7%)
Location
 Hand0 (0.0%)1 (9.1%)3 (27.3%)6 (54.5%)0 (0.0%)1 (9.1%)
 Feet9 (9.9%)38 (41.8%)27 (29.7%)14 (15.4%)0 (0.0%)3 (3.3%)